Medistep Healthcare Ltd., a fast-growing player in the pharmaceutical and personal care space, is set to open its ₹16.10 crore Initial Public Offering (IPO) on August 8, 2025. The issue will remain open for subscription until August 12, with the listing scheduled on the NSE SME platform on August 18.
This IPO marks a significant milestone for the company, which was incorporated just two years ago, and has rapidly scaled operations in both manufacturing and distribution of healthcare products. lets read more about Medistep Healthcare IPO GMP, Details and Date, IPO Lot size and more.
Medistep Healthcare Ltd Company Overview
Incorporated in 2023, Medistep Healthcare Ltd. operates in both manufacturing and trading segments of the healthcare industry. The company’s product range spans sanitary pads, energy powders, nutraceuticals, pharmaceuticals, intimate care items, and surgical products.
While the company manufactures select items like sanitary pads and energy powder in-house, it primarily earns revenue through the distribution and trading of healthcare products. In FY 2024–25, trading activities accounted for about 73.5% of its total revenue, while manufacturing contributed the remaining 26.5%.
With an emphasis on expanding its footprint in Tier II and Tier III cities across India, Medistep has built a strong distribution network that supports its vision of delivering accessible healthcare products to a wide population base.
Medistep Healthcare IPO Details
| Particulars | Details |
|---|---|
| IPO Opening Date | August 8, 2025 |
| IPO Closing Date | August 12, 2025 |
| Listing Platform | NSE SME |
| Listing Date | August 18, 2025 (Tentative) |
| Issue Price | Fixed at ₹43 per share |
| Lot Size | 3,000 shares |
| Minimum Investment | ₹1,29,000 |
| Total Issue Size | ₹16.10 crore (Approx.) |
| Shares Offered | 37.44 lakh equity shares |
| Registrar | Cameo Corporate Services Ltd. |
| Lead Manager | Fast Track Finsec Pvt. Ltd. |
The IPO is being issued entirely as a fresh equity offering, with no offer-for-sale (OFS) component. This means that all funds raised will go directly to the company to support its future growth.
Listing and Allotment Timeline
- IPO Opens: August 8, 2025
- IPO Closes: August 12, 2025
- Allotment Date: Expected around August 13–14
- Demat Credit / Refunds: By August 15, 2025
- Listing Date: August 18, 2025 (NSE SME platform)
Objectives of the Issue
Medistep Healthcare Limited intends to use the proceeds from the IPO for the following purposes:
- Purchase of plant and machinery to enhance manufacturing capabilities
- Working capital requirements
- General corporate purposes
By increasing its manufacturing infrastructure, the company aims to reduce dependency on third-party suppliers and improve margins through in-house production.
Fixed Price Issue at ₹43 Per Share
The Medistep Healthcare IPO is a fixed-price issue, with each equity share priced at ₹43. The total issue comprises 37.44 lakh shares, entirely offered as a fresh issue, meaning the company will receive the full proceeds.
The funds raised will be used for:
- Purchasing plant and machinery
- Meeting working capital requirements
- General corporate purposes
Financial Performance
Medistep Healthcare has shown solid growth in its financials over a short period:
- Revenue (FY25): ₹49.65 crore (up from ₹39.07 crore in the previous year)
- Profit After Tax (FY25): ₹4.14 crore (compared to ₹3.33 crore last year)
The company’s ability to grow its top and bottom line within a year of incorporation reflects its robust market strategy and efficient cost management.
Market Sentiment and IPO GMP
Although this IPO is unlisted, it has still received positive interest in the grey market, indicating strong investor sentiment. As of August 6, 2025, the grey market premium (GMP) for Medistep Healthcare’s IPO is around ₹12 per share, indicating a potential listing gain of around 28%. However, the GMP is unofficial and may fluctuate depending on market sentiment. Investors should focus on the company’s fundamentals rather than just the GMP.
Lot Size and Investment Limits
Retail investors must apply for a minimum of 6,000 shares, which translates to two lots, with an investment of ₹2,58,000. High Net-Worth Individuals (HNIs) need to apply for at least three lots (9,000 shares).
| Category | Lot Size | Shares | Investment |
|---|---|---|---|
| Retail | 2 lots | 6,000 | ₹2,58,000 |
| HNI | 3 lots | 9,000 | ₹3,87,000 |
Promoter Holding and Post-IPO Shareholding
The company is currently promoted by Girdhari Lal Prajapat, Dabhi Vipul Gobarbhai, and Prajapati Hetalben Girdharilal, who collectively hold 93.62% of the company’s pre-IPO share capital.
Post-issue, the promoter holding will reduce to 68.96%, reflecting the equity dilution from the public offer.
Reservation Breakdown
The IPO offers a balanced reservation split between retail and non-institutional investors (NIIs), with a separate portion reserved for the market maker.
- Market Maker Reservation: 1,89,000 shares
- Retail Individual Investors (RIIs): 47.52% of the net offer
- Non-Institutional Investors (NIIs/HNIs): 47.44% of the net offer
The registrar to the issue is Cameo Corporate Services Ltd., and the lead manager is Fast Track Finsec Pvt. Ltd.
How to Check Your Allotment Status
You can track your allotment in any of the following ways:
Registrar’s Website (Cameo Corporate Services Ltd.)“
- Visit the IPO allotment page
- Select “Medistep Healthcare Ltd.” from the list
- Enter your PAN, Demat ID, or application number to get your status
www.bajajfinserv.in
Stock Exchange Platforms (BSE/NSE)“
Alternatively, check your allotment status on the BSE or NSE website using your PAN or application number
Should You Subscribe?
Medistep Healthcare’s IPO may appeal to investors who want to make an early investment in an emerging company in sectors such as healthcare and FMCG. With a reasonable fixed price of ₹43 per share and a growing presence in semi-urban markets, the company presents an attractive growth story.
However, investors should also be mindful of the risks involved in SME listings, such as lower liquidity and market depth. It is advisable to assess one’s risk appetite and consult a financial advisor before investing.
Contact Details
Medistep Healthcare Ltd.
Free Way Trade Center, Nr. A-One Hotel, N.H.-8,
Narol Gam, Narol Daskroi, Ahmedabad, Gujarat, 382405
Phone: +91 87808 46963
Email: Info@medistephc.com
Website: https://www.medistephc.com/
Registrar:
Cameo Corporate Services Limited
Subramanian Building, No. 01, Club House Road, Chennai, Tamil Nadu, 600002
Phone: +91-44-28460390
Email: ipo@cameoindia.com
Website: https://ipo.cameoindia.com/
Final Thoughts
Medistep Healthcare Ltd.’s IPO arrives at a time when healthcare spending in India is on the rise, especially in non-metro regions. With a mixed model of manufacturing and trading, the company has laid the groundwork for scalable growth. For long-term investors comfortable with SME risks, this IPO might be worth a closer look.
Disclaimer: This article is for informational purposes only and is not a recommendation for investment. IPO investing carries risks, including market volatility and allocation uncertainty. Always consult a SEBI-registered financial advisor and review the DRHP before making an investment decision.
Leave a Reply